
|Articles|October 10, 2018
Allergan Joins TriNetX to Access Network of Real-World Data
Advertisement
Allergan, a global pharmaceutical company, has joined the TriNetX global research network in hopes to gain real-time access to patient populations in order to determine protocol feasibility, cohort analysis, and site identification. With TriNetX, Allergan is hoping that their researchers will be able to optimize the clinical trial design process and conduct observational studies with more speed and ease.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Global Breast Cancer Trials Show Progress in Diversity, But Gaps Remain
2
Bringing Clinical Trials Into the Digital Era with eConsent
3
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
4
Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema
5





.png)



.png)



.png)
.png)
